US Stock MarketDetailed Quotes

RVTY Revvity

Watchlist
  • 109.260
  • +0.920+0.85%
Close May 31 16:00 ET
  • 109.260
  • 0.0000.00%
Post 17:39 ET
13.48BMarket Cap86.71P/E (TTM)

About Revvity Company

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. With a global network and localized agility, the company serves a diverse range of organizations from pharmaceutical and biotech to clinical labs, academia, and governments. It is headquartered in Waltham, MA.

Company Profile

SymbolRVTY
Company NameRevvity
Listing DateJul 6, 1965
Founded1937
CEODr. Prahlad R. Singh, PhD
MarketNYSE
Employees11500
Securities TypeOrdinary Shares
Fiscal Year Ends12-29
Address940 Winter Street
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-781-663-6900

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Prahlad R. Singh, PhD
  • Director, President and Chief Executive Officer
  • 9.13M
  • Miriame Victor
  • Senior Vice President and Chief Commercial Officer
  • 1.70M
  • Maxwell Krakowiak
  • Senior Vice President and Chief Financial Officer
  • 2.75M
  • Daniel R. Tereau
  • Senior Vice President, Strategy and Business Development
  • --
  • Anita Gonzales
  • Vice President and Controller
  • --
  • Tajinder Vohra
  • Senior Vice President, Global Operations
  • 1.76M
  • Joel S. Goldberg
  • Senior Vice President, Administration, General Counsel and Secretary
  • 2.64M
  • Alexis P. Michas
  • Non-Executive Chairman of the Board
  • 465.08K
  • Dr. Sophie V. Vandebroek, PhD
  • Director
  • --
  • Michael A Klobuchar
  • Director
  • --
  • Samuel R. Chapin
  • Independent Director
  • 315.07K
  • Michelle McMurry-Heath
  • Independent Director
  • 290.07K
  • Dr. Frank R. Witney,, PhD
  • Independent Director
  • 295.07K
  • Michel Vounatsos
  • Independent Director
  • 305.07K
  • Dr. Peter Barrett,PhD
  • Independent Director
  • 310.07K
  • Pascale Witz, M. Sc.,M.B.A.
  • Independent Director
  • 290.07K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg